[Therapeutic effects of RAS inhibitor in IgA nephropathy].
Naoki
N
Kashihara
D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D018450:Disease Progression; D005922:Glomerulonephritis, IGA / Q000188:drug therapy*; D006801:Humans; D011507:Proteinuria / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors